Coming up next


65 million reasons

Every day, 65 million people in the world are hoping for a cure – for Epilepsy.

Epilepsy isn‘t exactly rare. 1% of the worldwide population is affected, that‘s 1 person in every 100 people.

Like Prince, the late musician: “I used to have seizures when I was young. My mother and father didn't know what to do or how to handle it.”

Or actor Hugo Weaving (known as Agent Smith from The Matrix blockbuster trilogy): “I probably had one major seizure a year. Every now and then I’d fall down and wake up to someone saying, 'Are you OK?'”


Uniting doctors and scientists

Located in the Marseille area, Epinext is one of the largest multi-disciplinary structures in France which focuses on epilepsy diagnosis, research and treatment.

It brings together five established world leaders in clinical epileptology, fundamental epilepsy research and computational neuroscience…



There is no single disease called “Epilepsy”. Actually, doctors have identified numerous forms of epilepsy until today, several of them only in the past 10 years. Each form of epilepsy calls for different diagnostic validation, varies in severeness and responds very differently to drugs or surgery.



Understanding what exactly happens in an epileptic brain and why, down to a molecular level is the hub of Epinext‘s activities because it drives everything else: better diagnosis, more realistic virtual surgery and promising new approaches for therapy.



At the heart of the Epinext federation is the translation of results from basic research and computational neuroscience into clinical practice, i.e. developing new therapeutic strategies for epilepsy.



Epinext strives to share their research results, actual patient cases and data, success stories and dead ends with the international science community as well as the general public.